MEMVIST Trademark

Trademark Overview

On Friday, July 23, 2010, a trademark application was filed for MEMVIST with the United States Patent and Trademark Office. The USPTO has given the MEMVIST trademark a serial number of 85091679. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2013. This trademark is owned by Bayer Schering Pharma AG. The MEMVIST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, diagnostic and radiopharmaceutical preparations for the detection of oncological diseases, systemic amyloid diseases and Alzheimer's disease, contrast media for use in X-ray, MRI and ultrasound
memvist

General Information

Serial Number85091679
Word MarkMEMVIST
Filing DateFriday, July 23, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, diagnostic and radiopharmaceutical preparations for the detection of oncological diseases, systemic amyloid diseases and Alzheimer's disease, contrast media for use in X-ray, MRI and ultrasound

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 27, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Schering Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerlin 13353
DE
Party NameBayer Schering Pharma AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerlin 13353
DE

Trademark Events

Event DateEvent Description
Monday, March 11, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 11, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 10, 2012EXTENSION 3 GRANTED
Tuesday, August 7, 2012EXTENSION 3 FILED
Tuesday, August 7, 2012TEAS EXTENSION RECEIVED
Tuesday, January 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2012EXTENSION 2 GRANTED
Friday, January 27, 2012EXTENSION 2 FILED
Friday, January 27, 2012TEAS EXTENSION RECEIVED
Friday, August 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2011EXTENSION 1 GRANTED
Monday, August 8, 2011EXTENSION 1 FILED
Wednesday, August 17, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2011TEAS EXTENSION RECEIVED
Tuesday, August 2, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Monday, November 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 8, 2010ASSIGNED TO LIE
Tuesday, October 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 15, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 15, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 15, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 6, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 6, 2010NON-FINAL ACTION E-MAILED
Wednesday, October 6, 2010NON-FINAL ACTION WRITTEN
Wednesday, September 29, 2010ASSIGNED TO EXAMINER
Tuesday, July 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 27, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

memvist preparations diseases disease alzheimer contrast media ultrasound amyloid systemic radiopharmaceutical